CDH1 and neoplasm: In EMT, ZEB1 represses the epithelial marker E-cadherin (CDH1) to weaken cell-cell adhesion, but enhances the mesenchymal marker N-cadherin (CDH2) to facilitate tumor progression by promoting cell migration and invasiveness6, 8–12.